Admission Circulating Cell-Free DNA Levels as a Prognostic Factor in Pediatric Burns

por Halpern, D., Cohen, A., Sharon, N., Krieger, Y., Silberstein, E., Michael, T., Douvdevani, A., Shoham, Y.
Publicado 2022

A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome

por Sethuram, S., Levy, T., Foss-Feig, J., Halpern, D., Sandin, S., Siper, P. M., Walker, H., Buxbaum, J. D., Rapaport, R., Kolevzon, A.
Publicado 2022

Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome

por Kolevzon, A., Breen, M. S., Siper, P. M., Halpern, D., Frank, Y., Rieger, H., Weismann, J., Trelles, M. P., Lerman, B., Rapaport, R., Buxbaum, J. D.
Publicado 2022

A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

por Fastman, J., Foss-Feig, J., Frank, Y., Halpern, D., Harony-Nicolas, H., Layton, C., Sandin, S., Siper, P., Tang, L., Trelles, P., Zweifach, J., Buxbaum, J. D., Kolevzon, A.
Publicado 2021